Taylor-Robinson SD - Search Results

1

Ablative Therapy for Unresectable Intrahepatic Cholangiocarcinoma: A Systematic Review and Meta-Analysis.

Yousaf A, Kim JU, Eliahoo J, Taylor-Robinson SD, Khan SA. Yousaf A, et al. J Clin Exp Hepatol. 2019 Nov-Dec;9(6):740-748. doi: 10.1016/j.jceh.2019.08.001. Epub 2019 Aug 19. J Clin Exp Hepatol. 2019. PMID: 31889756 Free PMC article. Review.

2

Increase in mortality rates from intrahepatic cholangiocarcinoma in England and Wales 1968-1998.

Taylor-Robinson SD, Toledano MB, Arora S, Keegan TJ, Hargreaves S, Beck A, Khan SA, Elliott P, Thomas HC. Taylor-Robinson SD, et al. Gut. 2001 Jun;48(6):816-20. doi: 10.1136/gut.48.6.816. Gut. 2001. PMID: 11358902 Free PMC article.

3

Guidelines for the diagnosis and treatment of cholangiocarcinoma: consensus document.

Khan SA, Davidson BR, Goldin R, Pereira SP, Rosenberg WM, Taylor-Robinson SD, Thillainayagam AV, Thomas HC, Thursz MR, Wasan H; British Society of Gastroenterology. Khan SA, et al. Gut. 2002 Nov;51 Suppl 6(Suppl 6):VI1-9. doi: 10.1136/gut.51.suppl_6.vi1. Gut. 2002. PMID: 12376491 Free PMC article. No abstract available.

4

Changing international trends in mortality rates for liver, biliary and pancreatic tumours.

Khan SA, Taylor-Robinson SD, Toledano MB, Beck A, Elliott P, Thomas HC. Khan SA, et al. J Hepatol. 2002 Dec;37(6):806-13. doi: 10.1016/s0168-8278(02)00297-0. J Hepatol. 2002. PMID: 12445422

5

DNA adducts, detected by 32P postlabelling, in human cholangiocarcinoma.

Khan SA, Carmichael PL, Taylor-Robinson SD, Habib N, Thomas HC. Khan SA, et al. Gut. 2003 Apr;52(4):586-91. doi: 10.1136/gut.52.4.586. Gut. 2003. PMID: 12631674 Free PMC article.

6

Unfriendly chemicals in pancreatic cancer.

Khan SA, Beck A, Carmichael PL, Taylor-Robinson SD. Khan SA, et al. Pancreatology. 2003;3(1):7-8. Pancreatology. 2003. PMID: 12683401 No abstract available.

7

Photodynamic therapy significantly improves survival outcomes in people with non-resectable cholangiocarcinoma.

Khan SA, Sharif AW, Taylor-Robinson SD. Khan SA, et al. Cancer Treat Rev. 2004 May;30(3):315-8. doi: 10.1016/j.ctrv.2004.01.010. Cancer Treat Rev. 2004. PMID: 15059655 No abstract available.

8

In vivo and in vitro nuclear magnetic resonance spectroscopy as a tool for investigating hepatobiliary disease: a review of H and P MRS applications.

Khan SA, Cox IJ, Hamilton G, Thomas HC, Taylor-Robinson SD. Khan SA, et al. Liver Int. 2005 Apr;25(2):273-81. doi: 10.1111/j.1478-3231.2005.01090.x. Liver Int. 2005. PMID: 15780050 Review.

9

Proton and phosphorus-31 nuclear magnetic resonance spectroscopy of human bile in hepatopancreaticobiliary cancer.

Khan SA, Cox IJ, Thillainayagam AV, Bansi DS, Thomas HC, Taylor-Robinson SD. Khan SA, et al. Eur J Gastroenterol Hepatol. 2005 Jul;17(7):733-8. doi: 10.1097/00042737-200507000-00007. Eur J Gastroenterol Hepatol. 2005. PMID: 15947550

10

p53 Mutations in human cholangiocarcinoma: a review.

Khan SA, Thomas HC, Toledano MB, Cox IJ, Taylor-Robinson SD. Khan SA, et al. Liver Int. 2005 Aug;25(4):704-16. doi: 10.1111/j.1478-3231.2005.01106.x. Liver Int. 2005. PMID: 15998419 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

378 results

Search Page